Thakkar Roopal bought ABBV
February 15, 2024 · Form 4 insider transaction
Thakkar Roopal bought 13,868 shares of AbbVie Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,868
Price
$0.00
Total value
N/A
InsiderThakkar Roopal
RoleOfficer
CompanyAbbVie Inc. (ABBV)
SecurityOption (Right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 15, 2024
Filing dateFebruary 20, 2024
Shares owned after13,868
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 7,775 on February 15, 2025, 7,775 on February 15, 2026, and 7,774 on February 15, 2027.